Forecast: Import of Ambergris, Civet, Musk for Pharmaceutical Use to Japan

The forecast for Japan's import of ambergris, civet, and musk for pharmaceutical use from 2024 to 2028 shows a declining trend. As of 2023, the volume stood at X thousand kilograms. From 2024 to 2028, the predicted annual volume changes are as follows: a decline of 2.87% from 2024 to 2025, a further 2.89% drop to 2026, a 2.92% decrease to 2027, and a 2.95% reduction by 2028. Over the five-year period ending in 2028, the compound annual growth rate (CAGR) indicates a consistent contraction, averaging around -2.91% annually.

Looking forward, key factors to monitor include shifts in international regulations on sourcing animal-derived ingredients, advances in synthetic alternatives, and potential changes in market demand driven by environmental and ethical considerations. These could significantly impact the forecasted decline or potentially alter the trend direction.